CRISM Therapeutics Corporation
AMMCF
$6.77
$6.573,309.57%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | -40.06% | 0.00% | 109.99% | 0.00% |
| Total Receivables | -- | -- | 0.00% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -- | -- | -- | 0.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 0.00% |
| Total Current Assets | 0.00% | -38.51% | 0.00% | -72.92% | 0.00% |
|
|
|||||
| Total Current Assets | 0.00% | -38.51% | 0.00% | -72.92% | 0.00% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.00% | -38.51% | 0.00% | -72.92% | 0.00% |
|
|
|||||
| Total Accounts Payable | 0.00% | 24.93% | 0.00% | 187.79% | 0.00% |
| Total Accrued Expenses | 0.00% | -90.53% | 0.00% | 41.04% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | -94.53% | 0.00% | 1,031.82% | 0.00% |
| Total Other Current Liabilities | 0.00% | -94.53% | 0.00% | 1,031.82% | 0.00% |
| Total Current Liabilities | 0.00% | -79.54% | 0.00% | 251.25% | 0.00% |
|
|
|||||
| Total Current Liabilities | 0.00% | -79.54% | 0.00% | 251.25% | 0.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 0.00% | -79.54% | 0.00% | 251.25% | 0.00% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retained Earnings | 0.00% | 0.11% | 0.00% | -99.95% | 0.00% |
| Treasury Stock & Other | -- | -- | 0.00% | 103.07% | 0.00% |
| Total Common Equity | 0.00% | -9.32% | 0.00% | -83.65% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.00% | -9.32% | 0.00% | -83.65% | 0.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | -9.32% | 0.00% | -83.65% | 0.00% |
|
|
|||||
